Conway Capital Management, Inc. Exact Sciences Corp Transaction History

Conway Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Dec 02, 2024	SELL	$35.61 - $76.23 $151,342 - $323,977	-4,250 Closed	0 $0
Q3 2021 Dec 02, 2024	SELL	$90.24 - $124.05 $47,376 - $65,126	-525 Reduced 10.99%	4,250 $406 Million
Q1 2021 Dec 02, 2024	SELL	$116.57 - $155.01 $17,485 - $23,251	-150 Reduced 3.05%	4,775 $629 Million
Q4 2020 Dec 02, 2024	BUY	$99.61 - $142.12 $490,579 - $699,941	4,925 New	4,925 $653 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Conway Capital Management, Inc. with notifications on news.